INQOVI 100 mg/1
CEDAZURIDINE and DECITABINE · TABLET, FILM COATED · Taiho Pharmaceutical Co., Ltd.
INQOVI is a tablet, film coated containing cedazuridine and decitabine at 100 mg/1, taken oral. Manufactured by Taiho Pharmaceutical Co., Ltd..
Key Facts
- Brand Name
- INQOVI
- Generic Name
- CEDAZURIDINE and DECITABINE
- NDC Code (Product)
64842-0727- Manufacturer
- Taiho Pharmaceutical Co., Ltd.
- Strength
- 100 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA212576
- Drug Class
- Nucleoside Metabolic Inhibitor [EPC]
- Marketing Start
- 07/07/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is INQOVI used for?
INQOVI contains CEDAZURIDINE and DECITABINE. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is INQOVI a controlled substance?
INQOVI is not classified as a controlled substance by the DEA.
What is the generic name for INQOVI?
The generic name for INQOVI is CEDAZURIDINE and DECITABINE. There are no other listed brand versions of CEDAZURIDINE and DECITABINE.
What is the NDC code for INQOVI 100 mg/1?
The NDC (National Drug Code) for INQOVI 100 mg/1 is 64842-0727, listed by Taiho Pharmaceutical Co., Ltd..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)